Private Advisory Group LLC Invests $970,000 in KKR & Co. Inc. (NYSE:KKR)

Private Advisory Group LLC purchased a new stake in shares of KKR & Co. Inc. (NYSE:KKR) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 7,430 shares of the asset manager’s stock, valued at approximately $970,000.

Several other institutional investors have also recently bought and sold shares of KKR. Wellington Management Group LLP lifted its position in shares of KKR & Co. Inc. by 219.5% during the fourth quarter. Wellington Management Group LLP now owns 16,206,904 shares of the asset manager’s stock worth $1,342,742,000 after purchasing an additional 11,134,363 shares in the last quarter. GQG Partners LLC bought a new position in KKR & Co. Inc. in the first quarter valued at approximately $217,004,000. Canada Pension Plan Investment Board raised its position in shares of KKR & Co. Inc. by 198.6% during the 2nd quarter. Canada Pension Plan Investment Board now owns 3,207,368 shares of the asset manager’s stock valued at $337,543,000 after acquiring an additional 2,133,290 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of KKR & Co. Inc. by 4.3% in the 4th quarter. Vanguard Group Inc. now owns 41,670,039 shares of the asset manager’s stock valued at $3,452,363,000 after purchasing an additional 1,728,782 shares during the period. Finally, Bank of New York Mellon Corp boosted its position in shares of KKR & Co. Inc. by 64.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 4,036,821 shares of the asset manager’s stock worth $424,835,000 after purchasing an additional 1,585,447 shares during the last quarter. Institutional investors own 76.26% of the company’s stock.

KKR & Co. Inc. Stock Up 1.9 %

Shares of KKR & Co. Inc. stock opened at $135.62 on Friday. The firm has a market cap of $120.35 billion, a PE ratio of 31.99, a P/E/G ratio of 1.14 and a beta of 1.62. The business’s 50 day simple moving average is $122.93 and its 200 day simple moving average is $111.07. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.07 and a current ratio of 0.07. KKR & Co. Inc. has a 52-week low of $53.72 and a 52-week high of $135.90.

KKR & Co. Inc. (NYSE:KKR) last posted its quarterly earnings data on Wednesday, July 31st. The asset manager reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.20. KKR & Co. Inc. had a net margin of 17.99% and a return on equity of 5.05%. The company had revenue of $4.17 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same period last year, the company earned $0.58 earnings per share. On average, analysts predict that KKR & Co. Inc. will post 3.97 earnings per share for the current fiscal year.

KKR & Co. Inc. Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, August 27th. Investors of record on Monday, August 12th were given a $0.175 dividend. This represents a $0.70 dividend on an annualized basis and a dividend yield of 0.52%. The ex-dividend date was Monday, August 12th. KKR & Co. Inc.’s dividend payout ratio is currently 16.51%.

Insider Buying and Selling

In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the transaction, the insider now directly owns 25,260,971 shares in the company, valued at $650,470,003.25. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, major shareholder Kkr Group Partnership L.P. sold 2,554,644 shares of the firm’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $18.85, for a total value of $48,155,039.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the transaction, the insider now directly owns 25,260,971 shares in the company, valued at approximately $650,470,003.25. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 39.34% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Morgan Stanley increased their target price on KKR & Co. Inc. from $107.00 to $143.00 and gave the company an “equal weight” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of KKR & Co. Inc. from $128.00 to $141.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. JMP Securities upped their target price on shares of KKR & Co. Inc. from $135.00 to $150.00 and gave the company a “market outperform” rating in a research note on Wednesday. Barclays lifted their price target on shares of KKR & Co. Inc. from $146.00 to $149.00 and gave the stock an “overweight” rating in a research report on Monday, October 7th. Finally, StockNews.com raised KKR & Co. Inc. to a “sell” rating in a research note on Monday, October 7th. One analyst has rated the stock with a sell rating, two have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $141.00.

KKR & Co. Inc. Company Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.